Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers.

Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers.

Item
http://www.wikidata.org/entity/Q37536656
Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinomaA comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement.The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.MYC-Driven Pathways in Breast Cancer Subtypes.Family matters: How MYC family oncogenes impact small cell lung cancer.CDK9: A key player in Cancer and Other Diseases.MYC overexpression with its prognostic and clinicopathological significance in breast cancer.CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant ChemotherapyEndocrine Resistance in Breast Cancer
P2860

Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers.

Item
http://www.wikidata.org/entity/Q37536656
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclin dependent kinase-9 medi ...... resistance in breast cancers.
@en
Cyclin dependent kinase-9 medi ...... resistance in breast cancers.
@nl
type
label
Cyclin dependent kinase-9 medi ...... resistance in breast cancers.
@en
Cyclin dependent kinase-9 medi ...... resistance in breast cancers.
@nl
prefLabel
Cyclin dependent kinase-9 medi ...... resistance in breast cancers.
@en
Cyclin dependent kinase-9 medi ...... resistance in breast cancers.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Cyclin dependent kinase-9 medi ...... resistance in breast cancers.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P698
P932